Company: MVIS
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001641172-25-022632
Chunk: 190

Company: MICROVISION, INC.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 4
Chunk 190
---
 financial statements
and a failure to meet our reporting obligations. Any such failure could cause investors to lose confidence in the accuracy of our financial
reports, harm our reputation, and adversely affect the market price of our common stock.

Our
internal controls over financial reporting beginning for fiscal year 2024 include controls of our subsidiary, MicroVision GmbH,
which became a significant subsidiary upon the closing of our acquisition of assets from Ibeo in 2023. Given the added complexity
stemming from the inclusion of our German subsidiary within our control environment, the risk of a material weakness in internal
controls will be higher than it has been to date.

Our
stock price has fluctuated in the past, has recently been volatile and may be volatile in the future, and as a result, investors in our
common stock could incur substantial losses.

Our
stock price has fluctuated significantly in the past, has recently been volatile, and may be volatile in the future. Over the 52-week
period ending August 1, 2025, our common stock has traded at a low of $0.80  and a high of $1.95. We may continue to experience sustained
depression or substantial volatility in our stock price in the foreseeable future unrelated to our operating performance or prospects.
For the six months ended June 30, 2025, we incurred a loss per share of $0.18.

As
a result of this volatility, investors may experience losses on their investment in our common stock. The market price for our common
stock may be influenced by many factors, including the following:

●
investor reaction to our business strategy;

●the
success of competitive products or technologies;

●
strategic developments;

●the
timing and results of our development and commercialization efforts with respect to our perception solutions and lidar sensors;

●changes
in regulatory or industry standards applicable to our solutions or technologies;

29

●variations
in our or our competitors’ financial and operating results;

●developments
concerning our collaborations or partners;

●developments
or disputes with any third parties that supply, manufacture, sell or market any of our products or component parts;

●developments
or disputes concerning patents or other proprietary rights, including patents, litigation matters and our ability to obtain patent protection
for our technology;

●actual
or perceived defects in any of our products, if commercialized, and any related product liability claims;

●our
ability or inability to raise additional capital and the terms on